Trials / Terminated
TerminatedNCT00901693
An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 452 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of AL-46383A Ophthalmic Solution for the treatment of adenoviral conjunctivitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AL-46383A Ophthalmic Solution | |
| DRUG | AL-46383A Ophthalmic Solution Vehicle |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2009-05-14
- Last updated
- 2014-05-22
Source: ClinicalTrials.gov record NCT00901693. Inclusion in this directory is not an endorsement.